Long-term health benefits of appetite suppressants remain unproven
Because of the increasing prevalence of obesity, prevention and treatment of overweight has become a major public health concern. In addition to diet and exercise, drugs are needed for patients who failed to lose weight with behavioral treatment. The current article aimed to summarize recent concern...
Main Author: | Francisco José Roma Paumgartten |
---|---|
Format: | Article |
Language: | English |
Published: |
Universidade de São Paulo
|
Series: | Revista de Saúde Pública |
Subjects: | |
Online Access: | http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0034-89102011000600022&lng=en&tlng=en |
Similar Items
-
Long-term health benefits of appetite suppressants remain unproven Beneficios de los inhibidores de apetito en la salud a largo plazo permanecen sin comprobación Benefícios dos inibidores de apetite à saúde a longo prazo permanecem sem comprovação
by: Francisco José Roma Paumgartten
Published: (2011-12-01) -
The burden of obesity in the current world and the new treatments available: focus on liraglutide 3.0 mg
by: Marcio C. Mancini, et al.
Published: (2017-05-01) -
Current obesity drug treatment
by: Marcio C. Mancini, et al.
Published: (2006-03-01) -
Pharmacologically induced weight loss is associated with distinct gut microbiome changes in obese rats
by: Ilott, N.E, et al.
Published: (2022) -
To evaluate efficacy and safety of Caralluma fimbriata in overweight and obese patients: A randomized, single blinded, placebo control trial
by: Ekta Arora, et al.
Published: (2015-01-01)